• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质衍生因子-1α对正常和慢性粒细胞白血病CD34+造血细胞的生物学效应。

Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells.

作者信息

Dürig J, Rosenthal C, Elmaagacli A, Heyworth C, Halfmeyer K, Kasper C, Novotny J, Dührsen U

机构信息

Department of Haematology, University Hospital Essen, Germany.

出版信息

Leukemia. 2000 Sep;14(9):1652-60. doi: 10.1038/sj.leu.2401875.

DOI:10.1038/sj.leu.2401875
PMID:10995013
Abstract

We compared the biological effects of the CXC chemokine SDF-1alpha on immunomagnetically purified CD34+ cells isolated from human normal bone marrow (NBM), leukapheresis products (LP) and patients with chronic myeloid leukaemia (CML). LP CD34+ cells showed a significantly stronger migration response to SDF-1alpha (100 ng/ml) than CD34+ cells isolated from the peripheral blood (PB) of CML patients (P < 0.05). The chemotactic response to SDF-1alpha was also reduced in CML BM CD34+ cells in comparison to NBM CD34+ cells but the observed differences were not statistically significant. In analogy to normal CD34+ cells circulating CML PB CD34+ cells were less responsive to SDF-1alpha than their BM counterparts (P < 0.05). Furthermore, SDF-1alpha elicited similar concentration-dependent growth suppressive effects on normal and CML CD34+ cells (P > 0.05) in colony-forming cell assays. We then demonstrated that SDF-1alpha triggers intracellular calcium increases in CD34+ cells and there were no differences in the time course and dose response characteristics of normal and CML CD34+ cells. The reduced migration response to SDF-1alpha in CML CD34+ cells was not due to a down-regulation of the SDF-1alpha receptor CXCR-4 as flow cytometric analysis revealed similar CXCR-4 expression levels on NBM, LP, CML PB and CML BM CD34+ cells (P > 0.05). Finally, no differences in the modulation of CXCR-4 levels in response to SDF-1alpha and serum were observed in CML and normal CD34+ cells. Our data suggest that the impaired chemotactic response of CML CD34+ cells to SDF-1alpha is not caused by a lack or complete uncoupling of CXCR-4, but may be due to an intracellular signalling defect downstream of the receptor.

摘要

我们比较了CXC趋化因子SDF-1α对从人正常骨髓(NBM)、白细胞分离产物(LP)以及慢性髓性白血病(CML)患者中免疫磁珠纯化的CD34+细胞的生物学效应。LP CD34+细胞对SDF-1α(100 ng/ml)的迁移反应显著强于从CML患者外周血(PB)分离的CD34+细胞(P < 0.05)。与NBM CD34+细胞相比,CML骨髓CD34+细胞对SDF-1α的趋化反应也降低,但观察到的差异无统计学意义。与正常CD34+细胞类似,循环中的CML PB CD34+细胞对SDF-1α的反应性低于其骨髓对应细胞(P < 0.05)。此外,在集落形成细胞试验中,SDF-1α对正常和CML CD34+细胞产生了相似的浓度依赖性生长抑制作用(P > 0.05)。然后我们证明SDF-1α可引发CD34+细胞内钙增加,正常和CML CD34+细胞在时间进程和剂量反应特征上无差异。CML CD34+细胞对SDF-1α迁移反应降低并非由于SDF-1α受体CXCR-4下调,因为流式细胞术分析显示NBM、LP、CML PB和CML骨髓CD34+细胞上CXCR-4表达水平相似(P > 0.05)。最后,在CML和正常CD34+细胞中,未观察到对SDF-1α和血清反应时CXCR-4水平调节的差异。我们的数据表明,CML CD34+细胞对SDF-1α趋化反应受损并非由CXCR-4缺乏或完全解偶联引起,而可能是由于受体下游的细胞内信号缺陷。

相似文献

1
Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells.基质衍生因子-1α对正常和慢性粒细胞白血病CD34+造血细胞的生物学效应。
Leukemia. 2000 Sep;14(9):1652-60. doi: 10.1038/sj.leu.2401875.
2
Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1.慢性粒细胞白血病(CML)患者的未成熟白血病CD34+CXCR4+细胞对趋化因子SDF-1的反应中,整合素依赖性迁移和黏附能力较低。
Stem Cells. 2002;20(3):259-66. doi: 10.1634/stemcells.20-3-259.
3
Distinct biological effects of macrophage inflammatory protein-1alpha and stroma-derived factor-1alpha on CD34+ hemopoietic cells.巨噬细胞炎性蛋白-1α和基质衍生因子-1α对CD34+造血细胞的不同生物学效应。
Stem Cells. 1999;17(2):62-71. doi: 10.1002/stem.170062.
4
Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.用SDF-1α或抗CXCR4抗体处理循环CD34(+)细胞可增强其迁移能力和在非肥胖型糖尿病/重症联合免疫缺陷小鼠中的重建潜力。
Exp Hematol. 2002 Sep;30(9):1061-9. doi: 10.1016/s0301-472x(02)00880-9.
5
Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.趋化因子基质细胞衍生因子-1α调节骨髓造血祖细胞上VLA-4整合素依赖的对纤连蛋白和血管细胞黏附分子-1的黏附。
Exp Hematol. 2001 Mar;29(3):345-55. doi: 10.1016/s0301-472x(00)00668-8.
6
The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.趋化因子受体CXCR-4在CD34+造血祖细胞和白血病细胞上表达,并介导由基质细胞衍生因子-1诱导的跨内皮迁移。
Blood. 1998 Jun 15;91(12):4523-30.
7
Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival.趋化因子SDF-1与细胞因子协同作用可增强循环CD34(+)细胞的增殖:对祖细胞存活的可能作用。
Blood. 2000 Feb 1;95(3):756-68.
8
The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha.BCR/ABL癌基因改变了对基质衍生因子-1α的趋化反应。
Blood. 1999 Dec 15;94(12):4233-46.
9
Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient.CXCR4整合到膜脂筏中可引发造血干/祖细胞对SDF-1梯度的归巢相关反应。
Blood. 2005 Jan 1;105(1):40-8. doi: 10.1182/blood-2004-04-1430. Epub 2004 Aug 24.
10
Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1alpha.正常和慢性粒细胞白血病造血祖细胞对巨噬细胞炎性蛋白-1α的差异反应特性
Leukemia. 1999 Dec;13(12):2012-22. doi: 10.1038/sj.leu.2401610.

引用本文的文献

1
The underestimated role of basophils in Ph chronic myeloid leukaemia.嗜碱性粒细胞在慢性粒细胞白血病中的作用被低估
Eur J Clin Invest. 2018 Oct;48(10):e13000. doi: 10.1111/eci.13000. Epub 2018 Aug 6.
2
Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph chronic myeloid leukemia.尼洛替尼与维格列汀对慢性粒细胞白血病的协同抗白血病作用评估
Exp Hematol. 2018 Jan;57:50-59.e6. doi: 10.1016/j.exphem.2017.09.012. Epub 2017 Oct 12.
3
Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia.
趋化因子作为慢性髓性白血病骨髓微环境的引导者
Int J Mol Sci. 2017 Aug 22;18(8):1824. doi: 10.3390/ijms18081824.
4
Expression of CD25 on leukemic stem cells in BCR-ABL1 CML: Potential diagnostic value and functional implications.BCR-ABL1 慢性粒细胞白血病中白血病干细胞上 CD25 的表达:潜在诊断价值及功能意义
Exp Hematol. 2017 Jul;51:17-24. doi: 10.1016/j.exphem.2017.04.003. Epub 2017 Apr 27.
5
Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.慢性髓性白血病中CD26 +白血病干细胞区室的定量评估:患者亚组、预后影响及技术方面
Oncotarget. 2016 May 31;7(22):33016-24. doi: 10.18632/oncotarget.9108.
6
Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms.骨髓增殖性肿瘤中微环境细胞的细胞因子调节
Mediators Inflamm. 2015;2015:869242. doi: 10.1155/2015/869242. Epub 2015 Oct 12.
7
Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?基础科学与转化肿瘤学中的癌症干细胞:我们能否将其转化为临床应用?
J Hematol Oncol. 2015 Feb 25;8:16. doi: 10.1186/s13045-015-0113-9.
8
Imatinib mesylate can help to direct natural immunity toward an anti-leukemic reactivity by acting on the bone marrow microenvironment.甲磺酸伊马替尼可以通过作用于骨髓微环境来帮助将天然免疫导向抗白血病反应。
Oncoimmunology. 2012 Mar 1;1(2):214-216. doi: 10.4161/onci.1.2.18112.
9
Differential effects of CXCR4 antagonists on the survival and proliferation of myeloid leukemia cells in vitro.CXCR4拮抗剂对体外髓系白血病细胞存活和增殖的不同作用。
Korean J Hematol. 2011 Dec;46(4):244-52. doi: 10.5045/kjh.2011.46.4.244. Epub 2011 Dec 27.
10
Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia.伊马替尼治疗诱导慢性髓系白血病患者产生 CD5+B 淋巴细胞和具有抗白血病反应性的 IgM 天然抗体。
PLoS One. 2011 Apr 18;6(4):e18925. doi: 10.1371/journal.pone.0018925.